<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HB9F3CE22AEAF4E969D97C28DE30A7B8D" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 8931 IH: Improving Access to Safe Medicines Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-09-21</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 8931</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220921">September 21, 2022</action-date><action-desc><sponsor name-id="C001103">Mr. Carter of Georgia</sponsor> (for himself and <cosponsor name-id="R000305">Ms. Ross</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Controlled Substances Act to require the Attorney General to remove a drug from scheduling within 180 days of a certain date pursuant to the recommendation of the Secretary of Health and Human Services, and for other purposes.</official-title></form><legis-body id="HECA69295E9A540FA9AEF837C6E9E0FE6" style="OLC"><section id="H625F5343DACB4EF5BC924EBB11D81992" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Improving Access to Safe Medicines Act of 2022</short-title></quote>.</text></section><section id="HF1FF4F7AD4E149CABF5106D8B5431E65"><enum>2.</enum><header>Expedited removal of a controlled substance from scheduling at the recommendation of the Secretary of Health and Human Services</header><text display-inline="no-display-inline">Section 201(j) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/811">21 U.S.C. 811(j)</external-xref>) is amended—</text><paragraph id="HA6A1D8697D1148F281771A7A6151657A"><enum>(1)</enum><text>in paragraph (1)—</text><subparagraph id="H0D8FF18779AF4B64938F0664C6561046"><enum>(A)</enum><text>by striking <quote>the date described in paragraph (2)</quote> and inserting <quote>the date described in paragraph (3)</quote>; and</text></subparagraph><subparagraph id="HB4A60A78BDC9437089E4966AA6EA6290"><enum>(B)</enum><text>by striking <quote>the procedures described in paragraph (3)</quote> and inserting <quote>the procedures described in paragraph (4)</quote>;</text></subparagraph></paragraph><paragraph id="H08DC32EDCA4142049D2A10A541974357"><enum>(2)</enum><text>by redesignating paragraphs (2) and (3) as paragraphs (3) and (4), respectively; and</text></paragraph><paragraph id="H65D2D501C9E748808A03929C18799663"><enum>(3)</enum><text>by inserting after paragraph (1) the following:</text><quoted-block style="OLC" id="H877127431B3E4E958C012D942A356FDD" display-inline="no-display-inline"><subsection id="H761919F4495D4993B05059558C175579"><enum>(2)</enum><text display-inline="yes-display-inline">If the Secretary of Health and Human Services recommends that the Attorney General remove any drug from the schedules under this title in accordance with this section and section 202, and the Attorney General determines there is no other legal basis to control the drug under this title, the Attorney General shall, not later than 180 days after the date described in paragraph (3), issue a proposed rule to remove the drug from the schedules in accordance with the procedures set forth in subsection (a). </text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section></legis-body></bill> 

